Cargando…

Non-pharmaceutical interventions and covid-19 burden in the United States: retrospective, observational cohort study

OBJECTIVE: To evaluate the adoption and discontinuation of four broadly used non-pharmaceutical interventions on shifts in the covid-19 burden among US states. DESIGN: Retrospective, observational cohort study. SETTING: US state data on covid-19 between 19 January 2020 and 7 March 2021. PARTICIPANTS...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahlers, Michael, Aralis, Hilary, Tang, Wilson, Sussman, Jeremy B, Fonarow, Gregg C, Ziaeian, Boback
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978758/
https://www.ncbi.nlm.nih.gov/pubmed/36936598
http://dx.doi.org/10.1136/bmjmed-2021-000030
_version_ 1784899587280994304
author Ahlers, Michael
Aralis, Hilary
Tang, Wilson
Sussman, Jeremy B
Fonarow, Gregg C
Ziaeian, Boback
author_facet Ahlers, Michael
Aralis, Hilary
Tang, Wilson
Sussman, Jeremy B
Fonarow, Gregg C
Ziaeian, Boback
author_sort Ahlers, Michael
collection PubMed
description OBJECTIVE: To evaluate the adoption and discontinuation of four broadly used non-pharmaceutical interventions on shifts in the covid-19 burden among US states. DESIGN: Retrospective, observational cohort study. SETTING: US state data on covid-19 between 19 January 2020 and 7 March 2021. PARTICIPANTS: US population with a diagnosis of covid-19. MAIN OUTCOME MEASURES: Empirically derived breakpoints in case and mortality velocities (ie, rate of change) were used to identify periods of stable, decreasing, or increasing covid-19 burden. Associations between adoption of non-pharmaceutical interventions and subsequent decreases in case or death rates were estimated by use of generalised linear models accounting for weekly variability across US states. State level case and mortality counts per day were obtained from the Covid-19 Tracking Project. State level policies on non-pharmaceutical interventions included stay-at-home orders, indoor public gathering bans (mild >10 or severe ≤10 people), indoor restaurant dining bans, and public mask mandates. National policies were not included in statistical models. RESULTS: 28 602 830 cases and 511 899 deaths were recorded during the study. Odds of a reduction in covid-19 case velocity increased for stay-at-home orders (odds ratio 2.02, 95% confidence interval 1.63 to 2.52), indoor dining bans (1.62, 1.25 to 2.10), public mask mandates (2.18, 1.47 to 3.23), and severe indoor public gathering bans (1.68, 1.31 to 2.16) in univariate analysis. In mutually adjusted models, odds remained elevated for orders to stay at home (adjusted odds ratio 1.47, 95% confidence interval 1.04 to 2.07) and public mask mandates (2.27, 1.51 to 3.41). Stay-at-home orders (odds ratio 2.00, 95% confidence interval 1.53 to 2.62; adjusted odds ratio 1.89, 95% confidence interval 1.25 to 2.87) was also associated with a greater likelihood of decrease in death velocity in unadjusted and adjusted models. CONCLUSIONS: State level non-pharmaceutical interventions used in the US during the covid-19 pandemic, in particular stay-at-home orders, were associated with a decreased covid-19 burden.
format Online
Article
Text
id pubmed-9978758
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-99787582023-03-16 Non-pharmaceutical interventions and covid-19 burden in the United States: retrospective, observational cohort study Ahlers, Michael Aralis, Hilary Tang, Wilson Sussman, Jeremy B Fonarow, Gregg C Ziaeian, Boback BMJ Med Research OBJECTIVE: To evaluate the adoption and discontinuation of four broadly used non-pharmaceutical interventions on shifts in the covid-19 burden among US states. DESIGN: Retrospective, observational cohort study. SETTING: US state data on covid-19 between 19 January 2020 and 7 March 2021. PARTICIPANTS: US population with a diagnosis of covid-19. MAIN OUTCOME MEASURES: Empirically derived breakpoints in case and mortality velocities (ie, rate of change) were used to identify periods of stable, decreasing, or increasing covid-19 burden. Associations between adoption of non-pharmaceutical interventions and subsequent decreases in case or death rates were estimated by use of generalised linear models accounting for weekly variability across US states. State level case and mortality counts per day were obtained from the Covid-19 Tracking Project. State level policies on non-pharmaceutical interventions included stay-at-home orders, indoor public gathering bans (mild >10 or severe ≤10 people), indoor restaurant dining bans, and public mask mandates. National policies were not included in statistical models. RESULTS: 28 602 830 cases and 511 899 deaths were recorded during the study. Odds of a reduction in covid-19 case velocity increased for stay-at-home orders (odds ratio 2.02, 95% confidence interval 1.63 to 2.52), indoor dining bans (1.62, 1.25 to 2.10), public mask mandates (2.18, 1.47 to 3.23), and severe indoor public gathering bans (1.68, 1.31 to 2.16) in univariate analysis. In mutually adjusted models, odds remained elevated for orders to stay at home (adjusted odds ratio 1.47, 95% confidence interval 1.04 to 2.07) and public mask mandates (2.27, 1.51 to 3.41). Stay-at-home orders (odds ratio 2.00, 95% confidence interval 1.53 to 2.62; adjusted odds ratio 1.89, 95% confidence interval 1.25 to 2.87) was also associated with a greater likelihood of decrease in death velocity in unadjusted and adjusted models. CONCLUSIONS: State level non-pharmaceutical interventions used in the US during the covid-19 pandemic, in particular stay-at-home orders, were associated with a decreased covid-19 burden. BMJ Publishing Group 2022-08-01 /pmc/articles/PMC9978758/ /pubmed/36936598 http://dx.doi.org/10.1136/bmjmed-2021-000030 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Research
Ahlers, Michael
Aralis, Hilary
Tang, Wilson
Sussman, Jeremy B
Fonarow, Gregg C
Ziaeian, Boback
Non-pharmaceutical interventions and covid-19 burden in the United States: retrospective, observational cohort study
title Non-pharmaceutical interventions and covid-19 burden in the United States: retrospective, observational cohort study
title_full Non-pharmaceutical interventions and covid-19 burden in the United States: retrospective, observational cohort study
title_fullStr Non-pharmaceutical interventions and covid-19 burden in the United States: retrospective, observational cohort study
title_full_unstemmed Non-pharmaceutical interventions and covid-19 burden in the United States: retrospective, observational cohort study
title_short Non-pharmaceutical interventions and covid-19 burden in the United States: retrospective, observational cohort study
title_sort non-pharmaceutical interventions and covid-19 burden in the united states: retrospective, observational cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978758/
https://www.ncbi.nlm.nih.gov/pubmed/36936598
http://dx.doi.org/10.1136/bmjmed-2021-000030
work_keys_str_mv AT ahlersmichael nonpharmaceuticalinterventionsandcovid19burdenintheunitedstatesretrospectiveobservationalcohortstudy
AT aralishilary nonpharmaceuticalinterventionsandcovid19burdenintheunitedstatesretrospectiveobservationalcohortstudy
AT tangwilson nonpharmaceuticalinterventionsandcovid19burdenintheunitedstatesretrospectiveobservationalcohortstudy
AT sussmanjeremyb nonpharmaceuticalinterventionsandcovid19burdenintheunitedstatesretrospectiveobservationalcohortstudy
AT fonarowgreggc nonpharmaceuticalinterventionsandcovid19burdenintheunitedstatesretrospectiveobservationalcohortstudy
AT ziaeianboback nonpharmaceuticalinterventionsandcovid19burdenintheunitedstatesretrospectiveobservationalcohortstudy